SCHEMBL23196653

SCHEMBL23196653

O=C(CS(=O)(=O)c1nc2ccccc2s1)c1ccc(O)c(O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 9/20 0.59
ALPG P10696 9/20 0.59
GCGR P47871 2/20 0.59
TOP1 P11387 2/20 0.53
MAPT P10636 5/20 0.49
ALDH1A1 P00352 5/20 0.49
LMNA P02545 4/20 0.49
HTT P42858 4/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA7 P43166 1/20 0.49
CA14 Q9ULX7 1/20 0.49
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
PSMB8 P28062 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26320536 0.90 ALPL (0.47) ALPLALPGGCGRTOP1MAPT
SCHEMBL16625012 0.77 ALDH1A1 (0.60) MAPTALDH1A1LMNAHTTKMT2A
SCHEMBL23196652 0.76 MAPT (0.45) ALPLALPGGCGRMAPTALDH1A1
SCHEMBL3466913 0.74 ALPG (1.00) ALPLALPGGCGRTOP1MAPT
SCHEMBL6200420 0.73 HSD11B1 (0.66) MAPTALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL7905772 0.72 ALDH1A1 (0.65) MAPTALDH1A1LMNAHTTKMT2A
SCHEMBL23196655 0.72 ALPG (0.58) ALPLALPGGCGRTOP1MAPT
SCHEMBL30149949 0.71 ALDH1A1 (0.67) MAPTALDH1A1LMNAHTTKMT2A
SCHEMBL3595617 0.71 ALDH1A1 (0.67) MAPTALDH1A1LMNAHTTKMT2A
SCHEMBL9636277 0.70 ALDH1A1 (0.65) MAPTALDH1A1LMNAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO US GOV VETERANS AFFAIRS (US) 2023-09-21 US disclosed
US-20210106567-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO US GOV VETERANS AFFAIRS (US) 2021-04-15 US disclosed
WO-2021067572-A2 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2021-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210106567-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO NFKBIA, NCBP1, NFKB1 ALPL 4374/4885ALPG 4545/4885GCGR 4625/4885
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO NFKBIA, NCBP1, NFKB1 ALPL 4374/4885ALPG 4545/4885GCGR 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.